MEK-IN-9
MEK-IN-9 (Compound 4-82) is a MEK inhibitor. MEK-IN-9 induces p15 and p27 protein. MEK-IN-9 can be used in the research of renal adenocarcinoma and colorectal cancer[1].
Product Specifications
CAS Number
[871701-39-2]
UNSPSC
12352005
Target
CDK; MEK
Related Pathways
Cell Cycle/DNA Damage; MAPK/ERK Pathway
Field of Research
Cancer
Smiles
O=C1C2=C(N(C)C(C(C)=C2N(C3=CC(NC(CO)=O)=CC=C3)C(N1C4CC4)=O)=O)NC5=CC=C(C=C5F)I
Molecular Formula
C26H23FIN5O5
Molecular Weight
631.39
References & Citations
[1]Toshiyuki Sakai, et al. 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h-pyrido’2,3-d! pyrimidine derivatives and related compounds for the treatment of cancer. WO2005121142A1. WIPO (PCT) . 2005-06-10.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1217253-01 0.02 mg (E-Coli)
Recombinant Campylobacter jejuni subsp.jejuni serotype O:6 Lipid-A-disaccharide synthase (lpxB)
Ask
View Details MBS1217253-02 0.02 mg (Yeast)
Recombinant Campylobacter jejuni subsp.jejuni serotype O:6 Lipid-A-disaccharide synthase (lpxB)
Ask
View Details